MDL 2299: In Re: Actos (Pioglitazone)

Actos Products Liability Litigation Library

Main menu

Skip to primary content
Skip to secondary content
  • Actos Medical Library
    • Animal Studies
    • Bladder Cancer and Diabetes
    • Bladder Cancer and Smoking
    • Bladder Cancer- General
    • Cardiovascular Safety
    • Increased Risk of BC with PIO Use
    • Liver Safety
    • No Increased Risk of BC with PIO Use
    • OADs that effectively lower HbA1c
    • Pioglitazone and Cancer
      • Pioglitazone & Bladder Cancer
        • No Link Between Pio & BC
        • Overviews of Potential Link
        • Positive Link Between Pio & BC
          • French Epidemiological Study 2011
          • Lewis 2011
      • Pioglitazone & Cancer
    • Pioglitazone- Efficacy and Benefits
    • PPARs- Cancer Treatment AND OR Therapy
    • PPARs- Harmful AND OR Helpful
    • PPARs- Mechanism Articles
    • TZDs and Cancer
  • Welcome

TZDs and Cancer

TZDs and Cancer

  • Chang 2011 – Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus  :LOAD Full PDF

  • Govindarajan 2007-Thiazolidinediones and the Risk of Lung_ Prostate_ and Colon Cancer in Patients With Diabetes  :LOAD Full PDF

  • Koro 2007 – Cancer risks in thiazolidinedione users compared to other anti-diabetic agents  :LOAD Full PDF

  • Ramos-Nino 2007 – Association between cancer prevalence and use of thiazolidinediones_Results from the Vermont Diabetes Information System  :LOAD Full PDF

  • Recent Posts

    Proudly powered by WordPress